Efavirenz (CAS: 154598-52-4) is a white to off-white crystalline pharmaceutical active ingredient in the non-nucleoside reverse transcriptase inhibitor class. It is used in combination antiretroviral therapy for the management of HIV-1 infection.
The molecule contains a chiral benzoxazinone core with cyclopropylethynyl and trifluoromethyl substituents, which are essential to its pharmacological activity.
High-purity Efavirenz is manufactured under controlled pharmaceutical quality standards for formulation, analytical, and research applications.